摘要
目的探讨术后规范辅助治疗对Ⅱ期乳腺癌患者预后的影响。方法回顾性分析68例Ⅱ期乳腺癌术后患者的临床资料,把术后接受规范辅助治疗的分为实验组,未接受的分为对照组,然后通过比较生存率来分析影响预后的因素。结果 68例患者中仅有21例(30.88%)患者接受了术后规范辅助治疗。实验组与对照组的5年生存率分别为95.23%和78.72%,10年生存率分别为80.95%和59.57%,2组差异有统计学意义(P<0.05)。影响Ⅱ期乳腺癌患者预后的独立因素还包括月经有无、HER-2状态(P<0.05)。结论术后规范辅助治疗能改善Ⅱ期乳腺癌患者的预后。
Objective To explore the influence of postoperative adjuvant therapy on stage Ⅱprognosis of breast cancer . Methods Clinical data of 68 cases of stageⅡbreast cancer patients were retrospectively analyzed ,and the patients were divided into the control group and the experimental group which received postoperative adjuvant therapy .Survival of the 2 groups were compared,and prognostic factors were analyzed .Results 21(30.88%) patients received postoperative adjuvant therapy .The 5-year survival rates of the experimental group and the control group were 95.23%and 78.72%.The 10-year survival rates of the experimental group and the control group were 80.95%and 59.57%.The difference was significant(P<0.05).The independent factors affecting prognosis of stage Ⅱbreast cancer also included whether menstrration and HER-2 status (P<0.05).Conclu-sion Sandardized postoperative adjuvant therapy can improve prognosis of stage Ⅱbreast cancer .
出处
《实用癌症杂志》
2014年第9期1127-1129,共3页
The Practical Journal of Cancer
关键词
术后规范辅助治疗
Ⅱ期乳腺癌患者
远期生存状况
Postoperative adjuvant therapy
StageⅡ breast cancer patients
Long-term survival status
